Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)1,226.00
  • Today's Change4.00 / 0.33%
  • Shares traded209.29k
  • 1 Year change-7.96%
  • Beta0.7221
Data delayed at least 20 minutes, as of Sep 24 2021 16:44 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Total returns on £1000

1Y
Fund/benchmarkChange
PriceThe Biotech Growth Trust PLC (Ordinary Share)-6.89%
NAVThe Biotech Growth Trust PLC (Ordinary Share)-3.36%
Morningstar's BenchmarkNASDAQ Biotechnology TR GBP--

Key statistics

On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,226.00, 8.46% above its 52-week low of 1,130.37, set on Aug 20, 2021.
52-week range
Today
1,130.37Aug 20 20211,750.00Feb 10 2021
Markit short selling activity
Low
Med
High
Shares outstanding41.67m
Market cap516.73m GBP
Total assets563.93m GBP
Total expense ratio1.09%
High1,230.00
Low1,206.00
Previous close1,222.00
Average volume81.11k
YTD Change-22.21%
Beta0.7221
Diluted NAV (est)1,318.65
Diluted NAV (last pub)1,325.54
Premium/Discount-6.42%
Net Gearing+1.30%
Data delayed at least 20 minutes, as of Sep 24 2021 16:44 BST.
More ▼

Board of Directors

1/7

Andrew Joy, Independent Non-Executive Chairman

2/7

Geoff Hsu, Non-Executive Director

3/7

Steve Bates, Independent Non-Executive Director

4/7

Professor Dame Kay Davies CBE, Independent Non-Executive Director

5/7

Lord Willetts, Independent Non-Executive Director

6/7

Julia Le Blan, Independent Non-Executive Director

7/7

Dr Nicola Shepherd, Independent Non-Executive Director

Contact

The Biotech Growth Trust PLC:
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image